A carregar...
Statistical considerations in the choice of endpoint for drug use disorder trials
BACKGROUND: To date, the US Food and Drug Administration (FDA) requires drug use disorder trials developing new medications to use abstinence, a clinically meaningful endpoint, as the primary outcome. Although abstinence is the gold standard, only a relatively small percentage of participants in dru...
Na minha lista:
| Publicado no: | Drug Alcohol Depend |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5687831/ https://ncbi.nlm.nih.gov/pubmed/29102827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.09.031 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|